Gelonghui, January 2, 丨 Renhe Pharmaceutical (000650.SZ) announced that as of December 31, 2023, the company had repurchased 9 million shares of the company's shares through a special stock repurchase securities account, accounting for 0.6429% of the company's current total share capital. The highest transaction price for the repurchase was 6.78 yuan/share, the minimum transaction price was 6.40 yuan/share, and the total amount paid was 6.723 million yuan (excluding transaction fees).
仁和药业(000650.SZ)：累计耗资6007.23万元回购900万股
Renhe Pharmaceutical (000650.SZ): A total cost of 6.0723 million yuan to buy back 9 million shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.